229 related articles for article (PubMed ID: 16310675)
1. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
Cole LA; Kohorn E; Smith HO
Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
[TBL] [Abstract][Full Text] [Related]
2. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
3. USA hCG reference service, 10-year report.
Cole LA; Laidler LL; Muller CY
Clin Biochem; 2010 Aug; 43(12):1013-22. PubMed ID: 20493830
[TBL] [Abstract][Full Text] [Related]
4. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
Khanlian SA; Cole LA
J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
[TBL] [Abstract][Full Text] [Related]
5. What we know about low-level hCG: definition, classification and management.
Kohorn EI
J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate management of women with persistent low hCG results.
Cole LA; Khanlian SA
J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
[TBL] [Abstract][Full Text] [Related]
7. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
Cole LA; Khanlian SA; Muller CY
J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
[TBL] [Abstract][Full Text] [Related]
8. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
Cole LA; Muller CY
Gynecol Oncol; 2010 Jan; 116(1):3-9. PubMed ID: 19822356
[TBL] [Abstract][Full Text] [Related]
10. Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases.
Hwang D; Hancock BW
J Reprod Med; 2004 Jul; 49(7):559-62. PubMed ID: 15305828
[TBL] [Abstract][Full Text] [Related]
11. The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers.
Cole LA; Kohorn EI
J Reprod Med; 2006 Oct; 51(10):793-811. PubMed ID: 17086808
[TBL] [Abstract][Full Text] [Related]
12. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
14. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
Faranesh R; Ben-David Y
Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
[TBL] [Abstract][Full Text] [Related]
15. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
Kohorn EI
Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
[TBL] [Abstract][Full Text] [Related]
16. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Cole LA; Sutton JM
J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
[TBL] [Abstract][Full Text] [Related]
17. Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic disease.
Khanlian SA; Smith HO; Cole LA
Am J Obstet Gynecol; 2003 May; 188(5):1254-9. PubMed ID: 12748494
[TBL] [Abstract][Full Text] [Related]
18. Choriocarcinoma and gestational trophoblastic disease.
Smith HO; Kohorn E; Cole LA
Obstet Gynecol Clin North Am; 2005 Dec; 32(4):661-84. PubMed ID: 16310678
[TBL] [Abstract][Full Text] [Related]
19. The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies.
Fisher RA; Savage PM; MacDermott C; Hook J; Sebire NJ; Lindsay I; Seckl MJ
Gynecol Oncol; 2007 Dec; 107(3):413-9. PubMed ID: 17942145
[TBL] [Abstract][Full Text] [Related]
20. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Cole LA; Sutton JM
J Reprod Med; 2006 Mar; 51(3):217. PubMed ID: 16674021
[No Abstract] [Full Text] [Related]
[Next] [New Search]
